- Full Year 2023 Molecular Partners AG Earnings Call TranscriptMar 15, 2024CHF3.4Earnings
- Molecular Partners AG at JPMorgan Healthcare Conference TranscriptJan 10, 2024
- Half Year 2023 Molecular Partners AG Earnings Call TranscriptAug 25, 2023CHF5.13 (-0.58%)Earnings
- Molecular Partners AG at TD Cowen Inc Radiopharmaceutical Innovation Summit (Virtual) TranscriptJun 20, 2023
- Molecular Partners AG at RBC Capital Markets Global Healthcare Conference TranscriptMay 17, 2023
- Full Year 2022 Molecular Partners AG Earnings Call TranscriptMar 10, 2023CHF5.82 (-1.36%)Earnings
- Molecular Partners AG at JPMorgan Healthcare Conference TranscriptJan 11, 2023
- Half Year 2022 Molecular Partners AG Earnings Call TranscriptAug 26, 2022CHF5.99 (+1.53%)Earnings
- Full Year 2021 Molecular Partners AG Earnings Call TranscriptMar 16, 2022CHF19.08 (+0.74%)Earnings
- Molecular Partners AG at JPMorgan Healthcare Conference (Virtual) TranscriptJan 12, 2022
- Molecular Partners AG Corporate Call TranscriptJan 10, 2022
- Molecular Partners AG to Host Oncology Day (Virtual) TranscriptDec 15, 2021
- Molecular Partners AG at Morgan Stanley Global Healthcare Conference (Virtual) TranscriptSep 10, 2021
- Half Year 2021 Molecular Partners AG Earnings Call TranscriptAug 26, 2021CHF18.12 (+0.22%)Earnings
- Molecular Partners AG at Cowen Healthcare Conference (Virtual) TranscriptMar 02, 2021
- Full Year 2020 Molecular Partners AG Earnings Call TranscriptFeb 05, 2021CHF21.35Earnings
- Molecular Partners AG at JPMorgan Healthcare Conference (Virtual) TranscriptJan 14, 2021
- Molecular Partners AG - Special Call TranscriptDec 17, 2020
- Molecular Partners AG at Morgan Stanley Global Healthcare Conference (Virtual) TranscriptSep 16, 2020
- Half Year 2020 Molecular Partners AG Earnings Call TranscriptAug 26, 2020CHF21.35Earnings
- Molecular Partners AG - Special Call TranscriptJun 26, 2020
- Full Year 2019 Molecular Partners AG Earnings Call TranscriptFeb 06, 2020CHF21.35Earnings
- Molecular Partners AG at JPMorgan Healthcare Conference TranscriptJan 16, 2020
- Molecular Partners AG - Special Call TranscriptDec 12, 2019
- Half Year 2019 Molecular Partners AG Earnings Call TranscriptAug 27, 2019CHF21.35Earnings
- Full Year 2018 Molecular Partners AG Earnings Call TranscriptFeb 07, 2019CHF21.35Earnings
Molecular Partners AG Corporate Call Transcript
Good day, and welcome to the EMPATHY Part A Top Line Results Call. (Operator Instructions) As a reminder, this call may be recorded. I would now like to turn the call over to Seth Lewis, Senior Vice President, Investor Relations. You may begin.
Thank you, Michelle. Good morning. And welcome to this conference call to review the positive top line data from Part A of the EMPATHY study, a global trial of ensovibep, a DARPin antiviral therapeutic for COVID-19.
My name is Seth Lewis, Senior Vice President of Investor Relations at Molecular Partners. And I'm joined this morning by Patrick Amstutz, Chief Executive Officer; [Chief] Officer; Michael Stumpp; Chief Operating Officer; and Nicolas Leupin. (technical difficulty) opening remarks.
And before we begin today's call, I'd like to remind, I'm making certain forward-looking statements and that these may be subject to change (technical difficulty) a public filing. (inaudible) to this on replay, this call was recorded
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)